Emerging biomarkers for RV maladaptation in pulmonary hypertension are long non-coding RNA H19, SPARC-like protein 1 (SPARCL1), and cartilage intermediate layer protein 1 (CILP1) [58]. The gene discussed is SPARCL1; the disease is pulmonary arterial hypertension.